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CytotoxicityDNA/Cationic liposome complexes (lipoplexes) have been widely used as non-viral vectors for transfection.
Neutral lipids in liposomal formulation are determinant for transfection efﬁciency using these vectors. In this
work, we studied the potential of monoolein (MO) as helper lipid for cellular transfection. Lipoplexes
composed of pDNA and dioctadecyldimethylammonium bromide (DODAB)/1-monooleoyl-rac-glycerol (MO)
at different molar ratios (4:1, 2:1 and 1:1) and at different cationic lipid/DNA ratios were investigated. The
physicochemical properties of the lipoplexes (size, charge and structure), were studied by Dynamic Light
Scattering (DLS), Zeta Potential (ζ) and cryo-transmission electron microscopy (cryo-TEM). The effect of MO
on pDNA condensation and the effect of heparin and heparan sulphate on the percentage of pDNA release
from the lipoplexes were also studied by Ethidium Bromide (EtBr) exclusion assays and electrophoresis.
Cytotoxicity and transfection efﬁciency of these lipoplexes were evaluated using 293 T cells and compared
with the golden standard helper lipids 1,2-dioleoyl-sn-glycero-3-hosphoethanolamine (DOPE) and
cholesterol (Chol) as well as with a commercial transfection agent (Lipofectamine™ LTX). The internalization
of transfected ﬂuorescently-labeled pDNA was also visualized using the same cell line. The results
demonstrate that the presence of MO not only increases pDNA compactation efﬁciency, but also affects the
physicochemical properties of the lipoplexes, which can interfere with lipoplex-cell interactions. The DODAB:
MO formulations tested showed little toxicity and successfully mediated in vitro cell transfection. These
results were supported by ﬂuorescence microscopy studies, which illustrated that lipoplexes were able to
access the cytosol and deliver pDNA to the nucleus. DODAB:MO-based lipoplexes were thus validated as non-
toxic, efﬁcient lipofection vectors for genetic modiﬁcation of mammalian cells. Understanding the relation
between structure and activity of MO-based lipoplexes will further strengthen the development of these
novel delivery systems.bromide; MO, 1-monooleoyl-
nolamine; DOTMA, 2,3-diokey-
l; DLS, Dynamic Light Scattering;
ctron microscopy
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Gene therapy is a promising strategy to deliver genes of
therapeutic interest to target cells, with consequent production of
desired proteins to counteract both inherited and acquired deﬁcien-
cies [1,2]. Although viral vectors are more potent in achieving
effective transfection, there are important issues associated with
this strategy, as the limitation in size of the DNA molecule that can be
delivered or the immunological and mutational risks involved [3].
Cationic liposomes appeared in the late 1980's as a promisingalternative to viral vectors, when Felgner and colleagues discovered
that complexes between DNA and 2,3-dioleyloxypropyl-1-trimethyl
ammonium chloride (DOTMA) cationic liposomes efﬁciently trans-
fected the COS-7 cell line [4]. Since then, a lot of effort has been put
into understanding the mechanisms underlying the transfection
process. On the other hand, the optimization of the DNA/lipid
formulations for improved transfection efﬁciency as function of
parameters such as charge ratio (+/−) [CR (+/−)], electrostatic
properties, size and structure of the lipoplexes, efﬁciency of DNA
complexation or effect of serum presence during transfection [5–14] is
also under investigation.
The addition of neutral lipids [also designated as helper agents, such
as dioleoyl-phosphatidyl-ethanolamine (DOPE) and cholesterol
(Chol)] to the lipid formulation favors the fusion of the lipoplexes
with cell membranes, due to its propensity to form non-lamellar
structures with negative curvature that are akin to membrane fusion
intermediates [15–17]. Therefore, helper lipids are important
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glycerol (MO), is an amphiphilic neutral lipid of natural origin.
Although monoolein has never been used before for gene delivery
purposes, the fact of presenting two inverted bicontinuous cubic
phases even in excess water (b90% w/w) [18], suggests that it can be
promising as a novel helper lipid.
Nevertheless, other additional aspects must also be considered in
terms of gene delivery. For an efﬁcient transfection process to occur,
three main biological barriers must be overcome: cell internalization,
escape from the endosome, and nuclear uptake. DNA dissociation from
the lipoplex constitutes itself a crucial step in the process, because the
liposomal systemmust be able to complex the nucleic acid, enter the cell
and release the DNA for it to become accessible to the transcription
apparatus [19]. For this reason, it becomes important to understandhow
DNA dissociates from the lipoplexes and how the systems interact with
cell membranes. Early studies of Xu and Szoka described that anionic
membranespromoted the liposome-DNAaggregate dissociation [20,21].
In 1999, Mounkes et al. identiﬁed proteoglycans (membrane receptors
consisting of a protein core and one or more anionic glycosaminoglycan
chains, including heparan, dermatan and chondroitin sulfates) as the
mediating agents for cationic liposome/DNA cellular uptake in vitro and
in vivo[22]. Wiethoff and colleagues soon supported this hypothesis, by
studying the interaction between lipoplexes and glycosaminoglycans
derived from heparin and heparan sulfate [23]. Lipoplex/proteoglycan
interactionwas suggested to dependupon threemajor aspects: the ionic
strength, the effect of helper lipids and the effect of glycosaminoglycan
structure. When the lipoplexes interacted with heparin and heparan
sulfate, the negative nature of the polyelectrolytes determined the
release of DNA from the lipoplex trough the same type of cooperative
process that had been responsible for the formation of the cationic
vesicles/DNA complexes [24].
Some of the earliest studies on lipoplex-cell interactions suggested
that the lipoplex fuses with the plasma membrane [4], but subsequent
experiments supported that internalization of lipoplexes mainly occurs
through endocytosis [25–27], although variationmay arise from the cell
model used [28]. Another hypothesis considers that fusion of lipoplex-
cell membrane is responsible for triggering and/or facilitating the
uptake of larger lipoplex particles through the endossomal pathway
[29]. The size of lipoplexes as well as the ability of the helper lipid to
destabilize the membranes and release the DNA, may play a major role
during their membrane binding and internalization [30].
In this work, we studied the interaction between pSV-β-gal
plasmid DNA and DODAB/MO cationic liposomes in Opti-MEM I
medium, focusing on the effects of MO content (4:1, 2:1 and
1:1 mol/mol) in the lipoplex and its CR (+/−). Using Ethidium
Bromide (EtBr) as an intercalating probe, it was possible to follow the
complexation process of DNA through the spectral decomposition of
its steady-state ﬂuorescence using two different environments (H2O
and DNA). To investigate the interaction between model proteogly-
cans and DNA, we added increasing amounts of heparin and heparan
sulfate to pre-formed lipoplexes and evaluated the quantity of DNA
released. Dynamic Light Scattering (DLS) and Zeta (ζ) Potential
measurements and cryo-TEM were also used to detect any structural
changes in the lipoplex, correlated with the processes of DNA
complexation and/or dissociation. The cytotoxicity and transfection
efﬁciency were also evaluated using a human cell line for in vitro
validation of the novel lipofection system.
2. Materials and methods
2.1. Materials
1,2-dioleoyl-sn-glycero-3-hosphoethanolamine (DOPE) was pur-
chased from Avanti Lipids (USA). 1-monooleoyl-rac-glycerol (MO),
cholesterol (Chol), Dulbecco's Modiﬁed Eagle's Medium (DMEM),
penicillin/streptomycin/amphotericin B (10 000 units/10 mg/25 μgper mL) solution, agarose gel, heparan sulfate and heparin from the
porcine intestinal mucosa were purchased from Sigma-Aldrich.
Dioctadecyldimethylammonium bromide (DODAB) was purchased
from Tokyo Kasei (Japan). Opti-MEM I Reduced Serum Medium was
purchased from Gibco (UK). The intercalating probe Ethidium
Bromide (EtBr) was purchased from Molecular Probes (UK). Heat-
inactivated Fetal Bovine Serum (FBS) and Lipofectamine™ LTX
Reagent were purchased from Invitrogen. The Wizard Plus Midipreps
DNA Puriﬁcation System and β-Galactosidase Enzyme Assay Systemwith
Reporter Lysis Buffer were purchased from Promega (USA). Label IT®
Fluorescein Plasmid Delivery Controlwas purchased from Mirus (USA).
2.2. Plasmid DNA preparation
pSV-β-gal plasmid DNA was ampliﬁed with Escherichia coli DHB4
competent cells. The pDNA was isolated and puriﬁed with the
Wizard® Plus Midipreps DNA Puriﬁcation System Extraction Kit. pDNA
was then resuspended in ultra-pure water at a nucleotidic phosphate
group concentration of 1.0 μg/μl (2.25 mM) determined by absorption
at 260 nm [31] with NanoDrop ND1000 Spectrophotometer. DNA
purity was also veriﬁed by determining the ratio of absorbance at
260/280 nm with the same equipment.
2.3. Liposomes preparation
For preparing the DODAB:MO liposomes, deﬁned volumes from the
stock solutions of DODAB and MO in ethanol (20 mM) were injected
under vigorous vortexing to an aqueous buffer solution of Tris–HCl
(30 mM) at 70 °C, so that the ﬁnal lipid concentration ([DODAB+MO])
was 1 mMand the different DODAB:MOmolar ratios (4:1, 2:1, and 1:1)
were obtained. Liposomes containing DOPE and Chol at molar ratio 4:1
were also used for comparison, as well as DODAB-based liposomes. The
samepreparation procedurewas followed for DODAB andDODAB:Chol,
while for DODAB:DOPE a predeﬁned volume of the DOPE stock solution
in chloroformwas previously transferred to an eppendorf. After solvent
evaporation under a nitrogen steam, the lipidic ﬁlm was resolubilized
with the addition of an appropriate volume of ethanol and DODAB
ethanolic solution (20 mM), and liposomes were prepared as described
to the ﬁnal concentration of 1 mM.
2.4. Lipoplexes preparation
Lipoplexes were prepared by incubating plasmid DNA with the
adequate DODAB:MO liposome solutions in Opti-MEM I medium at
25 °C. In the complexation procedure, cationic vesicles were added to
a pDNA solution (20 mM) in a single-step, promoting the mixture of
the components by 30 min stirring, generating lipoplexes with CRs
(+/−) 0.4, 0.8, 1.2, 1.6, 2.0 and 4.0. The CR (+/−) is an indicator of
balance between positive charges (given by the concentration of
ammonium groups present in DODAB) and negative charges (given by
the concentration of nucleotidic phosphate groups in pDNA, which
corresponds to nucleotide concentration) [32]:
CR +=−ð Þ = +½ −½  =
Ammonium groups from DODAB½ 
Phosphate groups from DNA½  ð1Þ
The different CRs (+/−) obtained resulted from the addition of
adequate volumes of cationic vesicles to the pDNA solution for all the
MO molar ratios studied. Another main compositional parameter of
cationic lipid/pDNA complexes is given by the ratio of neutral to
cationic surfactant. The membrane charge density (σM) is deﬁned as
the cationic charge per unit of area and, assuming a homogeneous
distribution of cationic and neutral lipids, is given by [33]:
σM =
eZNcl
NnlAnl + NclAcl
= 1− φnl
φnl + rφcl
 
× σcl ð2Þ
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neutral lipid, σcl=eZ/Acl is the charge density of the cationic lipid with
valence Z, and φnl=Nnl/(Nnl+Ncl) and φcl=Ncl/(Nnl+Ncl) are the
molar fractions of the neutral and cationic lipids, respectively.
For physicochemical characterization experiments, lipoplexes were
prepared in a cuvette by adding the desired volume of cationic liposome
solutions into 2.5 ml of pSV-β-gal plasmid DNA solution (20 μg/ml)
diluted in Opti-MEM I medium. For EtBr exclusion assays, an EtBr
aqueous solution ([EtBr]=7.0×10−6 M) was added to the DNA
solution leading to the intercalation of the probe. EtBr concentration
was kept six times lower than that of the pDNA in order to guaranty a
decrease in the probe ﬂuorescence directly proportional to the amount
of cationic lipid at a given nucleotide base concentration [34].
For cytotoxicity and cell transfection assays, lipoplexes were
prepared by adding the adequate liposome solutions to eppendorfs
containing 0.5 or 1.0 μg of plasmid DNA in Opti-MEM I medium, and
then transferred to wells of 24-multiwell plates.
2.5. Lipoplexes destabilization
Lipoplex stability was analyzed before and after addition of
endogenous glycosaminoglycan (GAG) negative polyelectrolytes
(heparin and/or heparan sulfate) to the pre-formed lipid/pDNA
complexes at CRs (+/−) 2.0 and 4.0. pDNA dissociation from the
complexes was visualized either by gel agarose electrophoresis
(25 °C) and EtBr exclusion assays (37 °C). In the latter, EtBr emission
spectra were recorded for each heparin addition, until a heparin
maximum concentration of 278 μM.
2.5.1. Ethidium bromide exclusion assays
The steady-state ﬂuorescence measurements were performed in a
Horiba Jobin Yvon Spex Fluorolog-3 spectroﬂuorimeter for each CR
(+/−) analyzed, after a 5 min agitation periodwith amagnetic stirrer.
Theﬂuorescence intensitiesweredetermined atλexc=510 nm,because
thiswavelength is known tobe an isobestic point for EtBr/DNAsolutions
[35]. All emission spectra were integrated, and the ratio of the areas for
the dye solutions and the standard was determined, after subtraction of
the solvent background. Each ﬂuorescence emission spectrum was
ﬁtted to a sum of two log-normal functions [18], corresponding to
different environment states (DNA and H2O). Assuming that the
quantum yield of EtBr in the lipoplex remains constant for all the CRs
(+/−), the percentage of complexed pDNA (α) at C.R.(+/−)x can be
determined from the spectral decomposition previously made [18]:
αat C:R: +=ð Þx =
∫ IDNAF at C:R: +=ð Þ0:0−∫ I25
∘C
F at C:R: +=ð Þx
∫ IDNAF at C:R: +=ð Þ0:0
0
@
1
A × 100: ð3Þ
In order to compensate the temperature variation from DNA
complexation (25 °C) to lipoplex destabilization (37 °C) and its
quenching effect on EtBr ﬂuorescence intensity, all emission spectra
were corrected according with the following equation [18]:
I37
∘C
F at C:R: +=ð Þx =
I25
∘C
F at C:R: +=ð Þx × I
37∘C
F at C:R: +=ð Þ0:0
I25F at C:R: +=ð Þ0:0
 !
×
1−αat highest C:R: +=ð Þx
1−αat C:R: +=ð Þ0:0
 !
:
ð4Þ
which enables the data to be plotted in the same temperature
conditions.
2.5.2. Electrophoresis assays
Lipoplexes were prepared by mixing pDNA (5 μg) with the
appropriate concentration of DODAB:MO (Tris–HCl 30 mM pH 7.4)
to form lipoplexes DODAB:MO (1:1), (2:1) (4:1) at CRs (+/−) 2.0 and4.0, as described. Subsequently, each type of lipoplex was incubated
with heparin (1.0×10−2 M) or heparan sulphate (2.5×10−2 M) at
room temperature (RT), 5 min with gentle stirring. Finally, plasmid
alone (0.5 μg) and lipoplexes were loaded onto a 0.8% agarose gel TAE
1× stained with EtBr (5×10−4 M) using 1× loading dye (Orange G).
Electrophoresis was carried out under a constant electric ﬁeld (110 V,
90 min) at RT.
2.6. Dynamic light scattering (DLS) assays
1 ml solutions of pDNA/DODAB:MO lipoplexes with different MO
contents (4:1, 2:1, and 1.1) at CRs (+/−) 0.25, 0.5, 0.75, 1.0, 1.5, 2.0
and 4.0 were prepared in Opti-MEM I culture medium and placed in
3 ml disposable polystyrene cuvettes for DLS measurements in a
Malvern ZetaSizer Nano ZS particle analyzer. Malvern Dispersion
Technology Software (DTS) was used with multiple narrow mode
(high resolution) data processing, and mean size (nm) average and
error values were considered.
2.7. Zeta (ζ) potential assays
1 ml solutions of pDNA/DODAB:MO lipoplexes with different MO
contents (4:1, 2:1, and 1.1) at CRs (+/−) 0.25, 0.5, 0.75, 1.0, 1.5, 2.0
and 4.0 were prepared in Opti-MEM I culture medium and placed in
0.7 ml universal dip cells for ζ-potential measurements in a Malvern
ZetaSizer Nano ZS particle analyzer. Malvern Dispersion Technology
Software (DTS) was used with mono-modal mode data processing,
and ζ-potential (mV) average and error values given by the program
were considered.
2.8. Cryo-TEM assays
For the cryo-TEM studies, cryo-TEM grids were prepared following
standardprocedures. Threemicroliter of lipoplexes sample at 1.2 mg/ml
in Tris–HCl buffer solution (pH 7.4) were placed onto 200-mesh holey
EM grids and vitriﬁed in liquid ethane at liquid nitrogen temperature
using a Vitrobot (FEI). Cryo-TEM grids were observed at liquid nitrogen
temperature on a FEG JEM2200-FS/CR transmission electron micro-
scope (JEOL) operated at 200 kV. Digital images were recorded on a
4 K×4 K CCD camera Ultrascan4000™ (GATAN) under low-dose
conditions and using DigitalMicrograph™ (GATAN) software in binned
mode. An in-column omega energy ﬁlter helped to record images with
improved signal tonoise ratio by zero-lossﬁltering. The energy selecting
slit width was set at 9 eV. The images presented here were taken using
thenominalmagniﬁcation of 50000 resulting in aﬁnal pixel size of 4.3 Å
with a defocus value ranging from −3 to −1 μm. The total electron
doses were on the order of 7–20 electrons/Å².
Several images were taken for each sample to assure that
reproducible and representative results were obtained. The pictures
here presented were processed and adjusted for brightness/contrast
balance. Fast Fourier Transform images (FFT) for speciﬁed zones are
shown in order to observe structural organization patterns and
distances between lipid layers.
2.9. Cell culture
The 293 T cell linewas cultured in DMEMmedium supplemented
with 10% (v/v) heat-inactivated FBS and penicillin/streptomycin/
amphotericin B (10 000 units/10 mg/25 μg per mL) solution, in a
humidiﬁed incubator containing 5% CO2, at 37 °C. Cells were passed
every 2 days using 0.05% Trypsin-EDTA solution, in order to
maintain sub-conﬂuency.
2.9.1. Cytotoxicity assay
The percentage of viable cells (293 T) was determined by the
Lactate Dehydrogenase (LDH) assay, after 48 h of incubation with
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Fig. 1. Lipoplexes' ability to promote pDNA complexation. Variation of the decomposed
ﬂuorescence intensities of EtBr in pDNA and H2O bands for different DODAB:MO molar
ratios (4:1), (2:1) and (1:1) at different CRs (+/−).
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(TPP, Switzerland) at a density of 2×105 cells per well in complete
culture medium. Immediately before lipoplex addition, the culture
medium was replaced and 100 μl of the interest lipoplex solutions
were added to each well. After 48 h incubation, the intra- and
extracellular LDH activities were determined as follows: the medium
(500 μl) was collected for determination of extracellular LDH, and
cells were lysed with Tris–HCl 15 mM (500 μl) through sonication to
obtain the intracellular LDH. The enzyme activity was then assessed at
RT on a microplate reader (Spectra Max 340PC), by following, during
3 min, the rate of conversion of reduced nicotinamide adenine
dinucleotide (0.28 mM NADH) to oxidized nicotinamide adenine
dinucleotide (NAD+), at 340 nm. Pyruvate 0.32 mM (in phosphate
buffer, pH 7.4) was used as substrate. The LDH released to the
extracellular medium was expressed as a percentage of the total
(extracellular+intracellular) LDH activity. Data from at least two
independent experiments were log transformed and expressed as
percentage of the control, which was considered as 100% of cellular
viability. One-way analysis of variance statistical test (ANOVA) was
used to assess the signiﬁcance of differences in comparison with the
experimental control group, followed by a Dunnett's post test. Pb0.05
was considered to be statistically signiﬁcant.
2.9.2. Transfection assay
293 T cells in exponential growth phase were seeded into 24-wells
plates 12–16 h before transfection, and 100 μl of the lipoplex solutions
(DODAB, DODAB:MO, DODAB:Chol and DODAB:DOPE) were added to
each well after culture medium replacement. Transfection of pDNA
was also carried out with the Lipofectamine™ LTX Reagent according
to manufacturer's instructions. β-galactosidase activity was evaluated
48 h later with the β-Galactosidase Enzyme Assay System with
Reporter Lysis Buffer, according to standard protocol [36]. Data from
three independent experiments were log transformed to obtain a
normal distribution and one-way analysis of variance statistical test
(ANOVA) was applied to identify differences across the various
groups, followed by a Turkey's post test. Pb0.05 was considered to be
statistically signiﬁcant.
2.10. Fluorescence microscopy
In order to follow the intracellular trafﬁcking of the lipoplexes in
293 T cells, a ﬂuorescein-labeled pDNA (Label IT® Fluorescein Plasmid
Delivery Control,λexc=355/λem=465 nm)wasused. ForDNA-DODAB:
MO complex formation, labeled pDNA (0.5 or 1 μg pDNA/well) and
DODAB:MO (2:1) or Lipofectamine™ LTX were diluted in OPTI-MEM I
medium in order to obtain lipoplexeswithCR (+/−) 4.0. After 3 and 6 h
of incubation, the 293 T cellswere observed by ﬂuorescencemicroscopy
(Olympus-IX71).
3. Results
3.1. Characterization of DNA complexation by EtBr exclusion assays
EtBr is a ﬂuorescent DNA intercalating probe that has a high
ﬂuorescence quantum yield when intercalated between basepairs
(emitting at 610 nm by direct excitation at 510 nm) and a low
ﬂuorescence quantum yield when dispersed in water environment
(emitting at 630 nm).
With increasing CR (+/−), a decrease in the pDNA band as
opposed to an enhancement of the H2O band is visible, conﬁrming the
condensation of pDNA and the exclusion of EtBr into aqueous
environment. By ﬁtting each EtBr ﬂuorescence emission spectrum
into a sum of two log normal functions corresponding to the different
environment states, it is possible to isolate the pDNA component from
the aqueous environment in EtBr ﬂuorescence, therefore enabling the
visualization of the lipoplex formation process (see SM1). Fig. 1 showsthe variation of total ﬂuorescence intensities of the two emission
bands of EtBr in H2O environment and intercalated in pDNA at
different molar ratios of DODAB:MO (4:1, 2:1 and 1:1), and different
CRs (+/−).
For CRs (+/−)b2.0, the increase on MO content promotes higher
pDNA complexation efﬁciencies as seen by the EtBr exclusion to H2O
(Fig. 1). At CR (+/−)=2.0, this tendency is maintained with the
percentages of complexed DNA for pDNA/DODAB:MO (4:1, 2:1, and
1:1) systems being, respectively, 30%, 60% and 85%.
However, for CR (+/−) 4.0, pDNA/DODAB:MO (4:1 and 2:1)
formulations reach highest pDNA complexation percentages (93.7%
and 94.2%, respectively), as compared to pDNA/DODAB:MO (1:1)
system, that maintains almost the same level of pDNA condensation
observed at CR (+/−) 2.0 (87.6%).
Fig. 2 shows the ζ-potential (A) and mean size (B) for free pDNA,
free vesicles and DNA/DODAB:MO lipoplexes of different CRs (+/−).
Pure pDNA in solution gives a ζ-potential of −30 mV and pure
cationic liposomes exhibit a positive zeta potential of +35 mV, similar
to all the three formulations used (Fig. 2A). The ζ-potential for all the
formulations increases until reaching a neutral value (isoelectric
point). The isoelectric point for all pDNA/DODAB:MO formulations
(4:1, 2:1 and 1:1) occurs at CR (+/−)=2.0. After the neutralization
point, the ζ-potential keeps increasing for all the formulations until
CR (+/−) 4.0, where the ζ-potential associated is around ~+20 mV
for all pDNA/DODAB:MO lipoplexes.
Fig. 2B shows the mean size of free pDNA, free vesicles and
pDNA/DODAB:MO (4:1, 2:1 and 1:1) lipoplexes at different
CRs (+/−) in Opti-MEM culture medium. The maximum lipoplex
mean size is reached when CR (+/−) is about 1.5, until which a
generic rule seems to apply: the higher the MO content, the smaller
the lipoplexes. After this CR (+/−), the mean size of the lipoplexes
starts decreasing. The pDNA/DODAB:MO (2:1) lipoplexes at
CR (+/−) 4.0 are the smallest (1700 nm), being almost half of
the mean size than the lipoplexes at CR (+/−) 2.0 (3000 nm).
Fig. 3 depicts Cryo-TEM imaging of pDNA/DODAB:MO lipoplexes at
C.R. (+/−) 4.0 (1 mM total lipid).
Cryo-TEM imaging reveals that pDNA/DODAB:MO (4:1 and 2:1)
lipoplexes at CR. (+/−) 4.0 exhibit a multilamellar structure
consisting of stacked alternating lipid bilayers and pDNA monolayers
(Fig. 3A and B). The analysis using Fast Fourier Transforms (FFT)
corroborates this observation, by denoting a mono-orientated
organization pattern at repeating distances of about 5 nm.
In contrast, pDNA/DODAB:MO (1:1) lipoplexes at C.R. (+/−) 4.0
(Fig. 3C) show a different morphology, with high-curvature zones
(Fig. 3C) where lipid bilayers seem to intercross each otherwith pDNA
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Fig. 2. Physicochemical characterization of lipoplexes. ζ-potential (A) and Mean Size (B) for free pDNA, free vesicles and DNA/DODAB:MO lipoplexes of different CRs (+/−).
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interpreted asmonoolein-rich domains that alternatewith DODAB-rich
domains presenting multilamellar organization (Fig. 3C). The Fourier
transform diagrams reveal that these monoolein-rich domains (Fig. 3C)
exhibit a distinct structural organization with bi-orientated patterns in
angles of 90° between them, consistent with the existence of cubic
inverted bicontinuous mesophases (lamellae distance ≈6 nm),
also visible in other pDNA/DODAB:MO (1:1) lipoplex preparations
(supplementary Fig. 2).
3.2. Assessment of pDNA complexation and destabilization
Since extracellular interactions of lipoplexes with anionic glycos-
aminoglycans are determinant for their internalization, and possibly
interfere with gene transfer, electrophoresis was used to visualize the
ability of formulations to complex pDNA and the lipoplexes resistance
to proteoglycans destabilization. Fig. 4 shows the resistance of
pDNA/DODAB:MO lipoplexes at CRs (+/−) 2.0 (Panel A) and 4.0
(Panel B), before and after the addition of heparin and heparan sulfate
as glycosaminoglycan (GAGs) models at 25 °C, determined by
electrophoretic mobility in agarose gel (0.8% w/w).Fig. 3. Cryo-TEM imaging of pDNA/DODAB:MO lipoplexes at C.R. (+/−) 4.0 (1 mM total lip
gray plot proﬁles for speciﬁed zones A′ and A′′. Panel B: pDNA/DODAB:MO (2:1) lipoplexes
Panel C: pDNA/DODAB:MO (1:1) lipoplexes complemented with FFT diagrams and gray ploComplexation of pDNA by the three different DODAB:MO (1:1, 2:1,
4:1) formulations is visible in lanes 1–3 of Fig. 4A and B, as well as the
existence of a residual bands corresponding to free pDNA. The
intensity of these free pDNA bands decreases with MO content
increase, which is in agreement with the values determined by EtBr
exclusion assays (Fig. 1). Lanes 4–6 and 7–9 show the lipoplexes
resistance to an excess of heparin and heparan sulphate (278 μM)
respectively, where the complex stability at CR (+/−) 2.0 (Fig. 4A) is
lower as compared to CR (+/−) 4.0 (Fig. 4B) as seen by the less
intense signals from free pDNA. It is also visible that heparin addition
has a more pronounced destabilizing effect compared to heparan
sulphate for both CRs (+/−) as the amount of free pDNA increases.
Comparing the different formulations, the destabilization level
follows the order of MO content decrease (1:1b2:1b4:1). EtBr
exclusion assays were also performed in order to better quantify the
percentage of dissociated pDNA at CRs (+/−) 2.0 and 4.0 with
increasing heparin concentration (Fig. 5A and B, respectively). When
pDNA is released from the complex, EtBr is intercalated again in the
pDNA structure and the emission intensity of EtBr increases. These
values were calculated with Eq. (3) using the spectral decomposition
presented in Fig. 1.id). Panel A: pDNA/DODAB:MO (4:1) lipoplexes complemented with FFT diagrams and
complemented with FFT diagrams and gray plot proﬁles for speciﬁed zones B′ and B′′.
t proﬁles for speciﬁed zones C′ and C′′.
Fig. 4. Gel electrophoresis of DODAB:MO lipoplexes upon incubation with heparin (HEP) or heparan sulphate (HS) at RT for 5 min. Lipoplexes were prepared with 5 μg pDNA. Panel
A: lane L: size marker (Ez Load, Bio-Rad); lane 0: plasmid (0.5 μg); lane 1, 4 and 7: DODAB:MO (1:1) (+/−) 2.0, incubated with HEP and incubated with HS, respectively; lane 2, 5
and 8: DODAB:MO (2:1) (+/−) 2.0, incubated with HEP andwith HS, respectively; lane 3, 6 and 9: DODAB:MO (4:1) (+/−) 2.0, incubated with HEP andwith HS, respectively. Panel
B: similar to panel A, but lipoplexes prepared at CR (+/−) 4.0. Whenever possible, the intensity of pDNA bands assessed by grapy plot proﬁles and corresponding to the percentage
of complexed DNA was determined by ImageJ software using the gel analyzer option with standard criteria (“[−]” means no measurable data).
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increase is evident on pDNA release from the lipoplexes pDNA/DODAB:
MO (4:1 and 2:1) at CRs (+/−) 2.0 and 4.0, as opposed to
pDNA/DODAB:MO (1:1) lipoplexes. The percentage of pDNA released
upon heparin addition at CR (+/−) 2.0 is very low for DODAB:MO (1:1)
(19,5%) compared with the pDNA release from DODAB:MO (4:1) (55%)
and DODAB:MO (2:1) (46,6%).
For higher concentrations of heparin (N50 μM), a gradual
reduction of pDNA release occurs for all the formulations at both
CRs (+/−). The pDNA/DODAB:MO (1:1) lipoplexes show the highest
resistance to pDNA release upon addition of heparin.
3.3. Transfection efﬁciency and cytotoxicity evaluation
The transfection efﬁciency of the lipoplexes in study was evaluated
and compared with that obtained with the commercial reagent
Lipofectamine™ LTX and the plain DODAB (Fig. 6A) at different
CR (+/−). The inﬂuence of the amount of pDNA per well was also
analyzed, as pDNA dosage is known to affect transfection efﬁciency. A
comparison with other liposomal formulations containing DOPE and
Chol as helpers was also performed (Fig. 6B).
As illustrated in Fig. 6A, the incorporation of MO in the liposomal
formulation resulted in a transfection efﬁciency improvement when
compared to the cationic lipid DODAB.When using 1 μg DNA/well, the
transfection levels of pDNA/DODAB:MO systems are of the same order
of magnitude as LipofectamineTM LTX. For a lower MO content
(pDNA/DODAB:MO (2:1 and 4:1) formulations), a dose effect
response (0.5 μg and 1 μg of pDNA) was observed. For higher MOB
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Fig. 5. Lipoplexes destabilization by heparin (HEP). Percentage of pDNA released from th
(A); and CR (+/−) 4.0 (B), after addition of increasing amounts of HEP.content (pDNA/DODAB:MO (1:1) formulation), the transfection
efﬁciencies remained constant at both CRs . Focusing on the standard
ratio of cationic lipid/helper lipid (1:1), we have decided to compare
the effect of MO with that of the most representative helper lipids
used for gene delivery (DOPE and Chol), in the same conditions
(1 μg of pDNA/well). Although the molar ratio (1:1) pDNA/DODAB:
MO at CR (+/−) 4.0 rendered transfection levels slightly lower than
DODAB:DOPE (1:1) and DODAB:Chol (1:1) formulations (Fig. 6B),
the statistical test one-way analysis of variance (ANOVA) did not
detect any statistical difference between the values. Interestingly, at
molar ratios (4:1) and (2:1) pDNA/DODAB:MO promoted a similar
or higher transfection efﬁciency when compared to DODAB:DOPE
and DODAB:Chol systems, at equivalent cationic lipid to neutral lipid
ratio (Fig. 6B).
Fig. 7 shows the effect of lipoplex CR (+/−) and liposome
composition DODAB:MO on 293 T cell viability after 48 h incubation.
Independently of the lipoplex composition, no signiﬁcant effects on
cell viability were observed and cell survival was consistently above
80% for all used formulations, although pDNA/DODAB:Chol (1:1)
and pDNA/DODAB:DOPE (1:1) exhibit slightly higher toxicity than
pDNA/DODAB:MO lipoplexes at different DODAB:MO molar fractions.
3.4. Fluorescence microscopy
pDNA/DODAB:MO (2:1) (+/−) 4.0 (chosen for achieving the
highest transfection efﬁciency) and pDNA/Lipofectamine lipoplexes
with ﬂuorescein-labeled pDNA were incubated with 293 T cells and
observed at 3 h and 6 h in an inverted ﬂuorescence microscope, in0
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Fig. 6. Reporter β-galactosidase activity 48 h after transfection with cationic lipoplexes.
A — Effect of lipoplex CR (+/−), liposome composition (DODAB:MO) and pDNA
amount on transfection efﬁciency of 293 T cells (0.5 μg [white bar]) or 1.0 μg DNA [gray
bar] per well), as determined by β-galactosidase activity; B — Comparison of the effect
of different helpers (MO, Chol or DOPE at molar ratios (4:1, 2:1 and 1:1) and CR (+/−)
4.0, with 1.0 μg DNA/well) on transfection efﬁciency of 293 T cells. Control: cells
incubated with free pDNA. The mean (+/−) SD was obtained from three independent
experiments.
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the cells (Fig. 8).
At 3 h post-transfection, labeled pDNA is readily seen at the cells'
surface and some cytoplasmatic staining is also detectable (Fig. 8C).
After 6 h of incubation, both DODAB:MO (2:1) and LipofectamineTM
LTX vectors induced a signiﬁcant level of ﬂuorescence inside the cells
(Fig. 8C, D and E), indicating that a considerable amount of labeled
pDNA was internalized by then.
In order to conﬁrm the nuclear localization of pDNA, co-staining
with ﬂuorescein-labeled pDNA and Hoechst 34342-labeled nuclei was
performed. The results obtained clearly demonstrated even more0.0
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Fig. 7. Evaluation of the cytotoxicity of MO-based lipoplexes. A— Effect of lipoplex
CR (+/−) and liposome composition (DODAB:MO) on 293 T cell viability determined
by LDH assays after 48 h of exposure with lipoplexes; B — Comparison of the effect of
different helpers (MO, Chol or DOPE at molar ratios (4:1, 2:1 and 1:1) and CR (+/−)
4.0, with 1.0 μg DNA/well) on 293 T cell viability determined by LDH assays after 48 h of
exposure with lipoplexes. Control: cells incubated with free pDNA. Themean (+/−) SD
was obtained from three independent experiments. The mean (+/−) SD was obtained
from at least of two independent experiments.readily the existence of internalized pDNA after 3 and 6 h incubation
with pDNA/DODAB:MO (2:1) lipoplexes (Fig. 9).
The white arrowheads indicate speciﬁc zones where pDNA/DODAB:
MO (2:1) lipoplexes are particularly visible in theproximity of 293 T cell
nucleus, especially 6 h after transfection.
4. Discussion
4.1. Physicochemical characterization
We have previously shown a high dependence of the DNA
complexation efﬁciency and lipoplex structure on the MO content
when studying the interaction of salmon spermDNAwith DODAB:MO
vesicles (2:1, 1:1 and 1:2) in Tris–HCl buffer solution [18]. This
dependence is possibly the consequence of the ﬂuidizing effect of MO
that favors lipid chains mobility, even in the absence of DNA [37].
In the sequence of these studies, we have successfully shown the
transfection of 293 T cells with pSV-β-gal plasmid/DODAB:MO (2:1)
lipoplexes [38,39]. These results led us to investigate the structural
differences of the systems with different MO contents, and how these
parameters affect the transfection efﬁciency.
In this work we investigated the physicochemical properties of
lipoplexes prepared by DODAB:MO (4:1, 2:1 and 1:1) vesicles and
plasmid DNA (pSV-β-galactosidase) and their transfection promoting
capacity in conditions similar to those used in commercial transfec-
tion kits (LipofectamineTM LTX Invitrogen). A comparison of the
effect of MO, DOPE and Chol as helpers was also made, in terms of
transfection efﬁciency and cell viability.
The differences between the three formulations, with respect to
the percentage of complexed pDNA, assayed by the EtBr exclusion
assay (Fig. 1) at low CRs (b2.0), reﬂect the ﬂuidizing nature of MO,
which favors lipid chains mobility facilitating the restructuring of the
liposome/pDNA cluster. When the CR (+/−) increases to 4.0, this
difference is minimized, most likely because the excess of positive
charges forces pDNA complexation, regardless the percentage of MO
contained in the lipoplexes.
The size of the particles analyzed by Dynamic Light Scattering
(DLS) also shows some value dependence on the formulation: the
higher the MO content, the smaller the lipoplexes. The maximum
lipoplex mean diameter (3000–4000 nm) is reached when CR (+/−)
is about 1.5, after which the mean diameter of the lipoplexes starts
decreasing until values rounding 1000 nm at CR (+/−) 4.0, showing
the pDNA condensation by the lipid chains. It should be pointed here
that the larger particle diameters detected (1000–4000 nm) as
opposed to the regular range (200–1000 nm) of sizes described in
the literature for other lipoplex formulations, should reﬂect the
inﬂuence of the Opti-MEM culture medium on the “swelling” of
liposomes and lipoplexes, possibly due to the interaction of serum
proteins with the particles [30]. In fact, the inﬂuence of the Opti-MEM
incubation medium on the overall lipoplex sizes has previously been
described by other authors like Almofti [13,29] and Hays [40].
ζ-potential characterizes the surface charge density of lipoplexes,
which is critical for interaction with the negative cell surfaces, and has
been reported to affect transfection efﬁciency [33]. The ζ-potential
behavior is particularly interesting due to the mismatch between the
sequence of the measured isoelectric experimental points and the
sequence of the theoretical membrane charge densities (σM) for the
three MOmolar fractions analyzed. Considering the cellular uptake of
lammelar LαC complexes, Eq. (2) can be used with Acl=45 2 and
Anl=37 2, values obtained from Langmuir–Blodgett isotherms (data
not shown). The expected values of σM for pDNA/DODAB:MO
lipoplexes (4:1, 2:1, 1:1) would be 0.017e/ 2, 0.014e/ 2 and
0.010e/ 2, respectively, which does not correspond to measured
isoelectric experimental determined ζ-potential technique. This may
be explained by the existence of DODAB orMO rich domains and/or by
the existence of conformational and structural variations among the
Fig. 8. Intracellular localization of ﬂuorescein-labeled pDNA delivered with MO-containing lipoplexes after 3 and 6 h of incubation. A — control cells; B — incubation with naked
plasmid; C— incubation with pDNA/Lipofectamine™ LTX lipoplexes at C.R. (+/−) 4.0 (0.5 μg DNA/well); D— incubation with pDNA/DODAB:MO (2:1) lipoplexes at C.R. (+/−) 4.0
(0.5 μg DNA/well); E — incubation with pDNA/DODAB:MO (2:1) lipoplexes at C.R. (+/−) 4.0 (1 μg DNA/well).
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assumed lamellar model, which seems to be corroborated by the size
variations observed by DLS (Fig. 2B). Although the formulations have
similar mean sizes and ζ-potentials at CR (+/−) 2.0, the process of
pDNA complexation is different and dependent onMOcontent (Fig. 1),
which again suggests structural variations between different formu-
lations. Cryo-TEM data (Fig. 3 and SM 2) support this hypothesis by
showing that pDNA/DODAB:MO (1:1) lipoplexes possess high curva-
ture zones, interpreted as monoolein-rich domains associated to cubic
inverted bicontinuous mesophases. This structural organization is
contrasting with pDNA/DODAB:MO (4:1 and 2:1) lipoplexes, whichFig. 9. Intra-nuclear localization of pDNA delivered with pDNA/DODAB:MO (2:1)
lipoplexes at C.R. (+/−) 4.0 (1.0 μg DNA/well), after 3 and 6 h of incubation. Co-staining
with ﬂuorescein-labeled pDNA and Hoechst 34342-labeled nuclei was performed. The
white arrowheads indicate speciﬁc nuclear uptake sites.exhibit multilamellar organization consistent with the presence of
DODAB-rich domains.
4.2. Destabilization of lipoplexes
As adsorption versus uptake of lipoplexes may be affected by
proteoglycans present at the cell surface, it is important to study their
important interaction during cell transfection [23]. Association of
lipoplexes with negative polyelectrolytes free in solution might also
be important in terms of unwanted loss of pDNA at the cell surface.
Gel electrophoresis was used to evaluate the effectiveness of all
formulations in complexating pDNA and for assessment of lipoplexes
resistance to model proteoglycans. All the tested liposomes were able
to complex pDNA and differences in terms of response to heparin and
heparan sulphate destabilization were found between lipoplexes at
CR (+/−) 2.0 and 4.0 (Fig. 4, Panel A versus Panel B). The lipoplexes
that migrate poorly during electrophoresis show different EtBr
intensities as a result of two factors: one is the smaller amount of
complexed pDNA as a result of destabilization by either heparin or
heparan sulfate, while the other is the fact that complexed pDNA
shows less EtBr emission as, depending on the CR (+/−) value, the
lipoplex formation results in its partial exclusion from intercalation
sites (Fig. 1). This last effect increases with the lipoplex CR (+/−).
The differences in brightness in controls without proteoglycans
(lanes 2 and 3 of panels A and B) are explained by the fact that at
CR (+/−) 2.0 the percentage of complexed pDNA is lower when
compared with CR (+/−) 4.0 (Fig. 1) for pDNA/DODAB:MO (4:1 and
2:1), which is not observed for pDNA/DODAB:MO (1:1, lane 1), that
showed a similar pDNA complexation efﬁciency at both CRs (Fig. 1).
In the presence of heparin (lanes 4, 5 and 6), lipoplexes at CR (+/−)
4.0 (panel B) release less pDNA than lipoplexes at CR (+/−) 2.0 (panel
A). The higher intensity of free pDNA in lanes 5 and 6 of panel A/B as
compared to lane 4, indicates that heparin does in fact promote a more
pronounced pDNA release from DODAB:MO (2:1) and (4:1) at both
CRs (+/−), when compared to the (1:1) molar fraction, which is in
agreement with the results presented in Fig. 1.
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when compared to heparin (lanes 4, 5 and 6 versus lanes 7, 8 and 9, in
bothpanels), because heparin is highly sulphated in this case (2.4 versus
1.2 in heparan sulphate groups/disaccharide unit) with a considerably
greater fraction of N-sulfated glucosamine monomers [23].
Although DODAB:MO (1:1) at (+/−) 2.0 was the system with
highest capacity to complexate pDNA (85%), it also showed the greatest
resistance to release pDNA, suggesting that this formulation has a
structure more resistant to proteoglycans' destabilization. In Fig. 5, it is
visible that lipoplexes pDNA/DODAB:MO (4:1 and 2:1) present the
same dissociating dynamic, with an initial phase of fast dissociation of
pDNA after addition of low concentrations of heparin (b50 μM)
followed by slow dissociation phase for higher heparin concentrations.
With an excess of heparin (278 μM) the percentage of pDNA release
followed the same behavior observed by gel electrophoresis for all the
tested formulations, with DODAB:MO (4:1)NDODAB:MO(2:1)N
DODAB:MO (1:1). We could also conﬁrm that the resistance and
stability of the lipoplexes in study increase with increasing MO content
and that none of them release all pDNA upon interaction with heparin.
The fact that the system (1:1) shows enhanced resistance to heparin
relatively to the others, suggests that pDNAdissociationmust bemainly
dependent on the lipoplex structure (assessed by cryo-TEMdata) rather
than by the ζ-potential or the lipoplex size.
4.3. Evaluation of DODAB:MO as transfection systems
The results presented in Fig. 6A show that DODAB:MO liposomes are
efﬁcient vectors for pDNA release into animal cells, presenting in vitro
cell transfection efﬁciencies comparable to the ones presented by the
commercial carrier Lipofectamine™ LTX (Invitrogen). Additionally,
when MO based systems were compared to the extensively used Chol
andDOPE in identical experimental conditions (molar and charge ratios
(4:1, 2:1, and 1:1) and 4.0, respectively), similar transfection and
cytotoxic levelswere obtained (Figs. 6B and 7), reinforcing the potential
of MO as a good adjuvant for non-viral vectors.
The transfection efﬁciency variations among the several DODAB:
MO formulations may be due to the MO content inﬂuence on the ﬁnal
physicochemical lipoplex properties (superﬁcial charge density, size
and structural organization). For low MO content (4:1 and 2:1), an
excess of DODAB on the liposomal formulation maintains the same
type of multilamellar organization characteristic of DODAB's curva-
ture pattern, as seen by cryo-TEM data (Fig. 3A and B). In this case,
DODAB's rigidity prevails over the MO's ﬂuidity, which results in a
lower pDNA complexation ability that is reﬂected by a higher
dependence of transfection efﬁciency on the quantity of pDNA per
well (0.5 or 1.0 μg pDNA).This is also visible by EtBr exclusion assays
at an intermediate C.R. (+/−) 2.0 (Fig. 1), where the pDNA/DODAB:
MO (4:1 and 2:1) lipoplexes are only able to condensate, respectively,
30% and 60% of pDNA. These lower pDNA complexation percentages
as compared to pDNA/DODAB:MO (1:1) lipoplexes at the same
C.R. (+/−) (85%) may explain why the transfection efﬁciency is
somewhat limited in the case of smaller quantity of pDNA per well
(0.5 μg pDNA) for these formulations. In terms of mean diameter
and ζ-potential of these structures, it is also interesting to notice
that below the isoelectric point (C.R. (+/−) 2.0), pDNA/DODAB:MO
(4:1 and 2:1) lipoplexes present higher sizes than pDNA/DODAB:MO
(1:1) formulation, which again reinforces the existence of large rigid
domains rich in DODAB and less able to complex pDNA than the 1:1
formulation.
Nevertheless, for cell transfection with 1.0 μg of pDNA per well, it is
interesting to observe that despite the low pDNA complexation
efﬁciency at C.R. (+/−) 2.0 for the pDNA/DODAB:MO (4:1 and 2:1)
lipoplexes, a high transfection efﬁciency was obtained. This suggests
that there is a critical lipoplex population whose increasing concentra-
tion is directly related to a higher transfection efﬁciency. The fact that
similar transfection efﬁciencies were observed for pDNA/DODAB:MO(4:1 and 2:1) despite their two times difference in pDNA complexation
percentage suggests that the initial unsaturated lipoplex population is in
fact the most representative in terms of ﬁnal cell transfection. At CR
(+/−) 4.0 the lipoplexes have an increased amount of pDNA content
and are probably saturated as no dose effect is observed in the
transfection efﬁciency. The high pDNA load compensates its high
relative rigidity. For high MO content (pDNA/DODAB:MO (1:1)
lipoplexes), both MO's curvature pattern and MO's relative ﬂuidity
prevail over DODAB's properties, giving the ﬁnal formulation a higher
ability to complex pDNA at lower nucleic acid quantities (no dose effect
response is observed). Meanwhile the ﬁnal lipoplex structure assumes
an inverted bicontinuous cubic mesophase organization in coexistence
with multilamellar structures (Fig. 3C). It is known that these non-
lamellar structural organizations are associatedwithhigher transfection
levels, as in the case of DOPE's characteristic inverted hexagonal
structures, which represent membrane fusion intermediates that
enhance the internalization process and the endossomal escape [15].
Overcomed theﬂuidity barrier for pDNA/DODAB:MO(1:1) lipoplexes,
it is also the structural organization that leads to differences in cell
transfection efﬁciency when compared to pDNA/DODAB:MO (4:1 and
2:1) lipoplexes. The existence of inverted bicontinuous cubicmesophases
in the pDNA/DODAB:MO (1:1) formulation (Fig. 3C) results in aggregates
more resistant to proteoglycans destabilization. Further studies compris-
ing a more hard-to-transfect cell line will probably better elucidate the
relative differences among the several DODAB:MO formulations.
The cellular uptake studies (Figs. 8 and 9) clearly show a time-
dependent accumulation of ﬂuorescently labeled plasmid inside the
cell, in the nucleus 6 h post-transfection.
5. Conclusions
In this work, we conclude that the ﬂuidising effect of MO may
contribute favorably to the complexation efﬁciency of pDNA in MO-
based lipoplexes. The complexation efﬁciency follows the order
(1:1)N(2:1)N(4:1). All DODAB:MO formulations successfully medi-
ated in vitro cell transfection, although pDNA/DODAB:MO (4:1 and
2:1) lipoplexes have demonstrated a dose response effect which was
not veriﬁed for pDNA/DODAB:MO (1:1) lipoplexes. When high MO
content is present, the appearance of inverted bicontinuous cubic
mesophases at pDNA/DODAB:MO (1:1) lipoplexes results in higher
pDNA compactation and higher lipoplex resistance to destabilizing
agents.
The lipoplexes tested did not demonstrate cytotoxic effects in
293 T cells and the levels of transfection efﬁciency were comparable
to those of Lipofectamine™ LTX, DODAB:Ch and DODAB:DOPE, which
are a promising result for the use of MO as a new helper lipid in these
type of non-viral systems.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.07.002.
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